Related Experiment Video
Updated: Dec 28, 2025
10:35
Microvascular Decompression: Salient Surgical Principles and Technical Nuances
Published on: July 5, 2011
47.0K
Prognostic nomogram for microvascular decompression-treated trigeminal neuralgia.
Wen-Bo Zhang1, Ya-Ying Zeng2, Bo-Wen Chang1
1Department of Neurosurgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Neurosurgical Review
|February 11, 2020
Summary
This study developed a prognostic nomogram to predict trigeminal neuralgia (TN) remission after microvascular decompression (MVD). The tool aids clinicians in assessing pain recurrence risk for better TN management.
Area of Science:
- Neurosurgery
- Medical Prognostics
Background:
- Trigeminal neuralgia (TN) is a debilitating neuropathic pain condition.
- Microvascular decompression (MVD) is a primary surgical treatment for TN, but prognostic factors for long-term outcomes require further elucidation.
Purpose of the Study:
- To develop and validate an effective prognostic nomogram for predicting the 3-year remission rate in patients with TN undergoing MVD.
- To identify key factors influencing the prognosis of MVD-treated TN.
Main Methods:
- Retrospective cohort study of 1054 TN patients (845 development, 209 validation cohorts).
- Multivariate Cox regression analysis to identify prognostic factors.
- Concordance index (C-index) and calibration curves used to assess predictive accuracy and discriminative ability.
Main Results:
- Key prognostic factors identified: patient age, atypical pain, vascular compression type, number of offending vessels, and prior MVD surgery.
- The nomogram demonstrated good predictive accuracy with a C-index of 0.767 in the development cohort and 0.749 in the validation cohort.
Conclusions:
- A validated prognostic nomogram can effectively predict the 3-year remission rate after MVD for TN.
- This tool can assist in clinical decision-making and patient counseling regarding pain recurrence after MVD treatment for TN.
